Product Description
Vitamin K, particularly as vitamin K2, is present in very little amounts even in a healthy Western diet. Vitamin K deficiency results in inadequate activation of MGP, which greatly impairs the process of calcium removal and increases the risk of calcification of the blood vessels. An increased intake of vitamin K2 could therefore lower calcium-associated health risks. Vitamin K2 is most active as the MK-7 form, which is present in natto. Research has shown that increased consumption of MK-7 leads to more activated osteocalcin, which is linked to increased bone-matrix formation and bone mineral density and, therefore, a lower risk of hip fracture. Those results were confirmed in a 3-year study with 944 women aged 20 to 79 years, which showed that intake of MK-7-rich natto was associated with the preservation of bone mineral density. One recent, double-blind, randomized clinical trial investigated the effects of supplemental MK-7, MenaQ7 (NattoPharma ASA, Hovik, Norway), within a 3-year period for a group of 244 postmenopausal women. The researchers found that a daily dose of 180 mcg was enough to improve bone mineral density, bone strength, and cardiovascular health.Feature
PROMOTES BONE HEALTH: Maintains bone density by aiding calcium transport to bones. An increased intake of vitamin K2 could therefore lower calcium-associated health risks.